New study finds gaps in maternal immunisation data sets
A study led by a University of Canterbury geospatial and population health expert has uncovered gaps in nationwide data that tracks maternal immunisation rates.
Climate change: threshold for dangerous warming will likely be crossed between 2027-2042
The threshold for dangerous global warming will likely be crossed between 2027 and 2042 – a much narrower window than the Intergovernmental Panel...
Bristol professor wins prestigious RCGP award
A University of Bristol Professor of Primary Health Care and an NIHR Senior Investigator has been awarded the George Abercrombie Award for his outstanding contributions to the literature of general practice.
University of Alberta virologist awarded Nobel Prize in Physiology or Medicine
Michael Houghton was awarded the 2020 Nobel Prize in Physiology or Medicine today in recognition of his discovery of the hepatitis C (HCV) virus.
ARC Future Fellowship recipients announced
Researchers from the University of Adelaide have been awarded more than $7.5 million in the latest Australian Research Council Future Fellowships.
Funding boost means sunny days for solar innovation
A $4.5 million funding boost will help researchers at The Australian National University (ANU) develop next-generation solar cell technology.
How to build healthier communities — and people
New guidelines show how changes to our built environment can help Canadians get more active, eat better and stay socially connected.
Global demand for cancer surgery set to surge
A new modelling study led by UNSW predicts demand for cancer surgery will rise by 52 per cent within two decades, with low-income countries bearing the greatest burden.
New documentary ‘de-westernises’ drag performance
A new documentary that aims to de-westernise drag performances will be screened at this week’s Manchester Pride festival.
Oxford University breakthrough on global COVID-19 vaccine
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019...
- Advertisement -
